Cargando…

Clinical utility of FDG-PET/CT for post-surgery surveillance of malignant pleural mesothelioma – Comparison with contrast-enhanced CT

OBJECTIVES: To assess the diagnostic accuracy of fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT) findings for recurrent malignant pleural mesothelioma (MPM) after a radical surgery procedure and their impact on clinical management in comparison with contrast-enhanc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kitajima, Kazuhiro, Hashimoto, Masaki, Katsuura, Takayuki, Kondo, Nobuyuki, Minami, Toshiyuki, Kuribayashi, Kozo, Hasegawa, Seiki, Kijima, Takashi, Yamakado, Koichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887579/ https://www.ncbi.nlm.nih.gov/pubmed/31827724 http://dx.doi.org/10.18632/oncotarget.27324

Ejemplares similares

Response to Immune Checkpoint Inhibitor Therapy in Patients with Unresectable Recurrent Malignant Pleural Mesothelioma Shown by FDG-PET and CT
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

Deep learning with deep convolutional neural network using FDG-PET/CT for malignant pleural mesothelioma diagnosis
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

Fluorodeoxyglucose versus Choline Positron Emission Tomography/Computed Tomography Response Evaluation in Two Malignant Pleural Mesothelioma Patients Treated with Talc Pleurodesis and Neoadjuvant Chemotherapy
por: Kitajima, Kazuhiro, et al.
Publicado: (2018)

Usefulness of Quantitative Bone Single-Photon Emission Computed Tomography/Computed Tomography for Evaluating the Treatment Response of Bone Metastasis in a Lung Cancer Patient
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

Incidence and Risk Factors of Chest Wall Metastasis at Biopsy Sites in Patients with Malignant Pleural Mesothelioma
por: Hashimoto, Masaki, et al.
Publicado: (2022)

Epigenetic Alterations and Biomarkers for Immune Checkpoint Inhibitors–Current Standards and Future Perspectives in Malignant Pleural Mesothelioma Treatment
por: Yoshikawa, Yoshie, et al.
Publicado: (2020)

Three tumor markers for improved efficacy in the management of patients with malignant pleural mesothelioma
por: Nakamura, Akifumi, et al.
Publicado: (2020)

Tumor‐associated macrophage‐derived inflammatory cytokine enhances malignant potential of malignant pleural mesothelioma
por: Horio, Daisuke, et al.
Publicado: (2020)

Tiny Obturator Node Metastasis from Prostate Cancer Not Shown by FDG-PET/CT, CT, or MRI Detected by (11)C-Choline PET/CT
por: Kitajima, Kazuhiro, et al.
Publicado: (2018)

FDG PET versus CT radiomics to predict outcome in malignant pleural mesothelioma patients
por: Pavic, M., et al.
Publicado: (2020)

Assessment of tumor response to neoadjuvant chemotherapy in patients with breast cancer using MRI and FDG-PET/CT-RECIST 1.1 vs. PERCIST 1.0
por: Kitajima, Kazuhiro, et al.
Publicado: (2018)

Present and future roles of FDG-PET/CT imaging in the management of gastrointestinal cancer: an update
por: Kitajima, Kazuhiro, et al.
Publicado: (2017)

Extrapleural pneumonectomy or pleurectomy/decortication for malignant pleural mesothelioma
por: Hasegawa, Seiki
Publicado: (2014)

Diagnostic Ability of FDG-PET/CT in the Detection of Malignant Pleural Effusion
por: Nakajima, Reiko, et al.
Publicado: (2015)

FDG PET/CT Response Evaluation in Malignant Pleural Mesothelioma Patients Treated with Talc Pleurodesis and Chemotherapy
por: Genestreti, Giovenzio, et al.
Publicado: (2012)

Pelvic MRI, FDG-PET/CT, and Somatostatin Receptor Scintigraphy Findings of Treatment-Related Neuroendocrine-Differentiated Prostate Cancer
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

Implementing CT tumor volume and CT pleural thickness into future staging systems for malignant pleural mesothelioma
por: Lauk, Olivia, et al.
Publicado: (2021)

Harmonized pretreatment quantitative volume-based FDG-PET/CT parameters for prognosis of stage I–III breast cancer: Multicenter study
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

Relationship Between Physical Function and Health Utility in Patients Undergoing Surgical Treatment for Malignant Pleural Mesothelioma
por: Tanaka, Takashi, et al.
Publicado: (2021)

Do we still need to debate the merits of pleurectomy/decortication vs. extrapleural pneumonectomy for malignant pleural mesothelioma?
por: Nakamura, Akifumi, et al.
Publicado: (2023)

Predictive value of interim FDG-PET/CT findings in patients with diffuse large B-cell lymphoma treated with R-CHOP
por: Kitajima, Kazuhiro, et al.
Publicado: (2019)

Development of an effective method utilizing fibrin glue to repair pleural defects in an ex-vivo pig model
por: Kondo, Nobuyuki, et al.
Publicado: (2020)

Quantitative bone SPECT/CT for evaluating treatment response in patient with sternoclavicular arthritis
por: Komoto, Hisashi, et al.
Publicado: (2022)

CT and MRI Findings of Inflammatory Myofibroblastic Tumor in the Bladder
por: Furukawa, Yoshitaka, et al.
Publicado: (2022)

Multidetector CT Findings and Differential Diagnoses of Malignant Pleural Mesothelioma and Metastatic Pleural Diseases in Korea
por: Kim, Yoon Kyung, et al.
Publicado: (2016)

Significance of Metabolic Tumor Volume at Baseline and Reduction of Mean Standardized Uptake Value in (18)F-FDG-PET/CT Imaging for Predicting Pathological Complete Response in Breast Cancers Treated with Preoperative Chemotherapy
por: Higuchi, Tomoko, et al.
Publicado: (2019)

Comparison of CT and integrated PET-CT based radiation therapy planning in patients with malignant pleural mesothelioma
por: Pehlivan, Berrin, et al.
Publicado: (2009)

(18)F-FDG PET/CT in Pleural Epithelioid Hemangioendothelioma
por: Albano, Domenico, et al.
Publicado: (2017)

Bevacizumab plus cisplatin/pemetrexed then bevacizumab alone for unresectable malignant pleural mesothelioma: A Japanese safety study
por: Nakano, Takashi, et al.
Publicado: (2020)

Usefulness of Quantitative Bone SPECT/CT for Evaluating Treatment Response in a Patient with Mandibular Osteomyelitis
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

Erratum: Multidetector CT Findings and Differential Diagnoses of Malignant Pleural Mesothelioma and Metastatic Pleural Diseases in Korea
por: Kim, Yoon Kyung, et al.
Publicado: (2016)

CT Findings of Primary Renal Angiosarcoma
por: Komoto, Hisashi, et al.
Publicado: (2021)

False-Negative 18F-Fluorodeoxyglucose PET/CT in Malignant Pleural Mesothelioma
por: Corbin, Haley, et al.
Publicado: (2021)

Pleuroperitoneal Mesothelioma: A Rare Entity on 18F-FDG PET/CT
por: Sahoo, Manas Kumar, et al.
Publicado: (2017)

FDG-PET/CT and CT Findings of a Benign Solitary Fibrous Tumor of the Kidney; Correlation with Pathology
por: Nakajima, Reiko, et al.
Publicado: (2015)

Usefulness of malignant pleural effusion for early cytological diagnosis of mesothelioma in situ: A case report
por: Yabuuchi, Yuki, et al.
Publicado: (2022)

(18)F FDG-PET/CT of malignant thymoma with pleural and diaphragmatic metastases
por: Gajendra, Smeeta, et al.
Publicado: (2016)

Case Report and Review of Literature: Familial Malignant Pleural Mesothelioma in a 39 Years Old Patient With an Inconclusive (18)F-FDG PET/CT Result
por: Idkedek, Mayar, et al.
Publicado: (2022)

Accurate Monitoring of the Response of Bone Metastases to Treatment in Patients with Prostate Cancer Using Choline PET/CT
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

Prognostic value of SUVmax on 18F-fluorodeoxyglucose PET/CT scan in patients with malignant pleural mesothelioma
por: Lim, Jun Hyeok, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_outfmispr35v452g1i57idj8b5